They can enhance the antibody-dependent cell-mediated cytotoxicity (ADCC) induced by natural killer cells, recruiting CD3+, CD8+, and CD56+ cells to the tumor core, enhancing the immune response within the tumor [19]. The gene discussed is NCAM1; the disease is neoplasm.